HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas

Blood

Volumn 99, Issue 2, 2002, Pages 609-617

  Urosevic, Mirjana ^a   Willers, Joerg ^a   Mueller, Beatrix ^a   Kempf, Werner ^a   Burg, Guenter ^a   Dummer, Reinhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN; INTERLEUKIN 10;

ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CLONAL VARIATION; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LARGE CELL LYMPHOMA; LYMPHOCYTIC INFILTRATION; LYMPHOKINE ACTIVATED KILLER CELL; MACROPHAGE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 0037079713     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.2.609     Document Type: Article

References (75)

1. Pathogenesis of cutaneous lymphomas
2. Cutaneous lymphomas
3. Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation
4. The immunopathogenesis of cutaneous T-cell lymphoma
5. Immunohistochemical expression of IL-10 in mycosis fungoides
6. Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (inter-feron-gamma receptor beta-chain)
7. Cytokines and cutaneous T-cell lymphomas
8. Cytokine expression in primary cutaneous germinal center cell lymphomas
9. Tumor-specific peptides in cutaneous T-cell lymphoma: Association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor
10. The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens
11. Serological detection of cutaneous T-cell lymphoma-associated antigens
12. Selective MHC expression in tumours modulates adaptive and innate antitumour responses
13. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: Relationship to HLA expression and host immunocompetence
14. Major histocompatibility complex class J and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome
15. Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course
16. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells
17. HLA-G expression: Immune privilege for tumour cells?
18. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies
19. Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma
20. Human leukocyte antigen-G: Immunotolerant major histocompatibility complex molecule in transplantation
21. HLA-G: A tolerance molecule from the major histocompatibility complex
22. The HLA-G gene is expressed at a low mRNA level in different human cells and tissues
23. Distribution of HLA-G alternative mRNAs including soluble forms in normal lymphocytes and in lymphoid cell-derived leukemia
24. HLA-G transcription studies during the different stages of normal and malignant hematopoiesis
25. HLA-G class I gene expression in normal and malignant hematopoietic cells
26. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells
27. A deficiency of placental IL-10 in preeclampsia
28. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10
29. Human leucocyte antigen-G and its recognition by natural killer cells
30. The immunotolerance role of HLA-G
31. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
32. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules
33. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily
34. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes
35. How do NK cells sense the expression of HLA-G class lb molecules?
36. HLA-G protein expression is not induced during malignant transformation
37. EORTC classification for primary cutaneous lymphomas: A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer
38. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes
39. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4
40. Investigation of the expression of housekeeping genes in non-Hodgkin's lymphoma
41. Structure and function of the human MHC class lb molecules HLA-E, HLA-F and HLA-G
42. HLA-G revisited
43. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
44. HLA-G: Expression in human keratinocytes in vitro and in human skin in vivo
45. Homozygous HLA-G*0105N healthy individuals indicate that membrane-anchored HLA-G1 molecule is not necessary for survival
46. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
47. Modulation of HLA-G expression in human thymic and amniotic epithelial cells
48. Synergistic induction of HLA class I expression by RelA and CIITA
49. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile
50. T-cell clones from early-stage cutaneous T-cell lymphoma show no polarized Th-1 or Th-2 cytokine profile
51. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma
52. Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G
53. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition
54. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis
55. Interleukin-10 in cutaneous disorders: Implications for its pathophysiological importance and therapeutic use
56. A review of the association between interleukin-10 and human B-cell ma lignancies
57. Nonclassical HLA-G molecules are classical peptide presenters
58. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association
59. Peripheral blood mononuclear cells from women with recurrent abortion exhibit an aberrant reaction to release cytokines upon the direct contact of human leukocyte antigen-G-expressing cells
60. Presence of HLA-G-expressing cells modulates the ability of peripheral blood mono-nuclear cells to release cytokines
61. Primary cutaneous lymphomas other than mycosis fungoides
62. Cytokines as regulatory proteins in lymphoproliferative skin infiltrates
63. Primary cutaneous T-cell lymphoma: Review and current concepts
64. Transformation of mycosis fungoides/Sezary syndrome: Clinical characteristics and prognosis
65. + cutaneous lymphomas
66. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions
67. Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G
68. Is antigen presentation the primary function of HLA-G?
69. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immuno-histochemical study in 20 patients
70. Granulomatous slack skin. Report of three patients with an updated review of the literature
71. Modulation of HLA-G antigens expression by human cytomegalovirus: Specific induction in activated macrophages harboring human cytomegalovirus infection
72. Modulation of HLA-G antigens expression in myelomonocytic cells
73. NK cell recognition of non-classical HLA class I molecules
74. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells
75. LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells